These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


258 related items for PubMed ID: 30935922

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
    Goyal N, Tiwary S, Kesharwani D, Datta M.
    J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Molecular characterization and quantification of the follicle-stimulating hormone receptor in turbot (Scophthalmus maximus).
    Jia Y, Sun A, Meng Z, Liu B, Lei J.
    Fish Physiol Biochem; 2016 Feb; 42(1):179-91. PubMed ID: 26358315
    [Abstract] [Full Text] [Related]

  • 25. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism.
    Qu S, Altomonte J, Perdomo G, He J, Fan Y, Kamagate A, Meseck M, Dong HH.
    Endocrinology; 2006 Dec; 147(12):5641-52. PubMed ID: 16997836
    [Abstract] [Full Text] [Related]

  • 26. RNA sequencing of db/db mice liver identifies lncRNA H19 as a key regulator of gluconeogenesis and hepatic glucose output.
    Goyal N, Sivadas A, Shamsudheen KV, Jayarajan R, Verma A, Sivasubbu S, Scaria V, Datta M.
    Sci Rep; 2017 Aug 16; 7(1):8312. PubMed ID: 28814771
    [Abstract] [Full Text] [Related]

  • 27. Epigallocatechin Gallate Inhibits Hepatic Glucose Production in Primary Hepatocytes via Downregulating PKA Signaling Pathways and Transcriptional Factor FoxO1.
    Li X, Chen Y, Shen JZ, Pan Q, Yang W, Yan H, Liu H, Ai W, Liao W, Guo S.
    J Agric Food Chem; 2019 Apr 03; 67(13):3651-3661. PubMed ID: 30875211
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice.
    Tanaka H, Nagashima T, Shimaya A, Urano Y, Shimokawa T, Shibasaki M.
    Eur J Pharmacol; 2010 Oct 25; 645(1-3):185-91. PubMed ID: 20655898
    [Abstract] [Full Text] [Related]

  • 32. Type I neuregulin1α is a novel local mediator to suppress hepatic gluconeogenesis in mice.
    Arai T, Ono Y, Arimura Y, Sayama K, Suzuki T, Shinjo S, Kanai M, Abe SI, Semba K, Goda N.
    Sci Rep; 2017 Feb 20; 7():42959. PubMed ID: 28218289
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.
    Pan Q, Ai W, Chen Y, Kim DM, Shen Z, Yang W, Jiang W, Sun Y, Safe S, Guo S.
    Diabetes; 2023 Sep 01; 72(9):1193-1206. PubMed ID: 37343276
    [Abstract] [Full Text] [Related]

  • 35. Forkhead box protein O1 (FoxO1) regulates hepatic serine protease inhibitor B1 (serpinB1) expression in a non-cell-autonomous fashion.
    El Ouaamari A, O-Sullivan I, Shirakawa J, Basile G, Zhang W, Roger S, Thomou T, Xu S, Qiang G, Liew CW, Kulkarni RN, Unterman TG.
    J Biol Chem; 2019 Jan 18; 294(3):1059-1069. PubMed ID: 30459233
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. SCP4 Promotes Gluconeogenesis Through FoxO1/3a Dephosphorylation.
    Cao J, Yu Y, Zhang Z, Chen X, Hu Z, Tong Q, Chang J, Feng XH, Lin X.
    Diabetes; 2018 Jan 18; 67(1):46-57. PubMed ID: 28851713
    [Abstract] [Full Text] [Related]

  • 38. Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway.
    Deng L, Shoji I, Ogawa W, Kaneda S, Soga T, Jiang DP, Ide YH, Hotta H.
    J Virol; 2011 Sep 18; 85(17):8556-68. PubMed ID: 21697492
    [Abstract] [Full Text] [Related]

  • 39. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity.
    Chen CC, Lee TY, Kwok CF, Hsu YP, Shih KC, Lin YJ, Ho LT.
    Int J Mol Med; 2016 Mar 18; 37(3):743-54. PubMed ID: 26847930
    [Abstract] [Full Text] [Related]

  • 40. Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis.
    Xiong X, Tao R, DePinho RA, Dong XC.
    PLoS One; 2013 Mar 18; 8(8):e74340. PubMed ID: 24015318
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.